Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home Pharmaceutical

Health Bulletin 16/December/2022

admin by admin
December 16, 2022
in Pharmaceutical


Here are the top health news for the day:

NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical seats, starting new PG courses

Noting that many institutes missed the opportunity to submit their requests, the National Medical Commission (NMC) has reactivated the online portal for applications by medical institutions seeking permission for the establishment of new medical colleges and intake increase of MBBS and PG medical seats or starting new PG courses for the academic year 2023-24. The deadline for the same is set till 23 December 2022.

For the Academic Session 2023-24, the last date for submitting applications for the MBBS course was 31st August 2022 and Post Graduate Courses was 20th, July 2022.

For more details, check out the link given below:

NMC Re-Invites Applications For Establishment Of New Medical Colleges, Intake Increase Of MBBS, PG Medical Seats, Starting New PG Courses

CDSCO opines J&J to submit details of anticancer drug Teclistamab approval in EU, US

In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the Subject Export Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has opined the firm to submit patients characteristics along with transplant history if any, treatment details and details of approval of the drug in EU and US for further deliberation.

For more details, check out the link given below:

CDSCO Opines J&J To Submit Details Of Anticancer Drug Teclistamab Approval In EU, US

Dr Sanjeev Gulati takes charge as 52nd president of Indian Society Of Nephrology

Dr Sanjeev Gulati, Executive Director, Nephrology and Kidney Transplant of Fortis Group of Hospitals, NCR has recently been elected as the President of the Indian Society of Nephrology (ISN). He was appointed as the 52nd President of ISN at its annual conference in Pune.

Congratulating the doctor over the great success, Fortis Hospital authorities stated that this evaluation of the doctor serves as a testament to his lifelong commitment towards the well-being of patients.

For more details, check out the link given below:

Dr Sanjeev Gulati Takes Charge As 52nd President Of Indian Society Of Nephrology

Madras HC raps Govt for withholding certificates of doctors, orders to ensure immediate bond service postings

Expressing concern over delayed bond service postings, the Madras High Court has recently slammed the Government for forcing super speciality and post graduate doctors to be idle by withholding their educational certificates.

The HC bench comprising Justice R. Subramanian also took note of the fact that the State Health Department of Tamil Nadu is neither offering government jobs to doctors who need to fulfill two-year bond service conditions after passing out of the government medical colleges, nor releasing their educational certificates. Therefore, these doctors are not even able to pursue higher education or get private jobs.

For more details, check out the link given below:

Madras HC raps govt for withholding certificates of doctors, orders to ensure immediate bond service postings



Source link

Tags: appointmentbondbond servicecancercancer DrugCDSCOCentral Drug Standard Control OrganizationDr Sanjeev GulatiFortis hospitalIndian Society Of NephrologyJnJjohnson ad johsnon newsJohnson and johnsonMadras High CourtMBBSmedical collegeNational Medical CommissionNMCPG medical seatsTeclistamab
Previous Post

A new benchmark: National average drug acquisition cost

Next Post

Oncologists Overwhelmed; Cluster Headaches; and Liver Cancer Cost

Next Post

Oncologists Overwhelmed; Cluster Headaches; and Liver Cancer Cost

Recommended

Health Bulletin 17/ December/ 2022

December 17, 2022

FDA Approves Xenoview for Evaluating Lung Ventilation

December 30, 2022

Don't miss it

Pharmaceutical

Strange bedfellows lobby for Medicare obesity-drug coverage

January 26, 2023
Medicines & Healthy Lifestyle

FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis

January 26, 2023
Medicines & Healthy Lifestyle

This Cancer Drug Can Increase Longevity, Study Finds

January 26, 2023
News

Something in Breast Milk Helps Protect Babies Against Allergies

January 26, 2023
Pharmaceutical

Merck ends late-stage trial for Keytruda in prostate cancer

January 25, 2023
Medicines & Healthy Lifestyle

Are Seed Oils Behind the Majority of Diseases This Century?

January 25, 2023

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.